Pharmacogenomics describes interpatient genetic variability in drug responses. Information
based on whole genome sequencing will soon open up the field of pharmacogenomics and …

Background Pharmacogenomics describes inter-patient genetic variability in drug
responses. Information based on whole genome sequencing will soon open up the field of …

Despite increasing interest in pharmacogenomics, and the potential benefits to improve
patient care, implementation into clinical practice has not been widespread. Recently, there …

Background: Patients respond to medications differently because of variations in the genes
that determine medication exposure and medication response. Objective: The aim of this …

There is considerable inter-individual variability in the effectiveness and safety of
pharmaceutical interventions. This phenomenon can be attributed to a multitude of factors; …

Methods The observations made in this paper draw on a broad literature review conducted
during a research internship with the Nuffield Council on Bioethics' Working Party on …

Abstract Introduction Pharmacogenomics (PGx) testing services have been delivered
through community pharmacies across the globe, though not yet in the UK. This paper is …

Introduction: There is limited empirical evidence on patients 'and healthcare professionals
'views on the provision of pharmacogenetic testing services. These opinions may be used to …

Background Despite healthcare professionals (HCP) endorsing the clinical utility of
pharmacogenomics testing, use in clinical practice is limited. Aims To assess …

Introduction Aberrant pharmacogenetic variants occur in a high proportion of people and
might be relevant for the prescription of over 26 drugs in primary care. Early identification of …